Latest Forum Topics /
EFH Ltd
Last:0.046
-0.003
|
 Post Reply
|
|
The Place Holdings on its next leg!
|
|||||
|
Sgvale
Supreme |
08-Jul-2020 09:41
|
||||
|
x 0
x 0 Alert Admin |
Wait till engine start & buy into momentum | ||||
| Useful To Me Not Useful To Me | |||||
|
ST3-trading
Senior |
07-Jul-2020 18:55
|
||||
|
x 0
x 0 Alert Admin |
haix .ZOG is hitting record high in stocks . | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
ST3-trading
Senior |
07-Jul-2020 15:51
|
||||
|
x 0
x 0 Alert Admin |
lost it creditably how to draw investor ? unless u telling me the product is die die must have one | ||||
| Useful To Me Not Useful To Me | |||||
|
iApple
Member |
07-Jul-2020 15:41
Yells: "trade to learn,learn to trade? " |
||||
|
x 0
x 0 Alert Admin |
The worst performance on SGX does not mean , it has no potential. Just that BB is not eyeing for it. |
||||
| Useful To Me Not Useful To Me | |||||
|
Sgvale
Supreme |
07-Jul-2020 15:32
|
||||
|
x 0
x 0 Alert Admin |
Biolidics has to refine their strategies while the world is still in the midst of covid-19 for fast marketing execution for their test kit product & capability. | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
money38
Member |
07-Jul-2020 15:22
|
||||
|
x 0
x 0 Alert Admin |
worst medical counter in the entire sgx, puizzz, to hv bot it at high price
|
||||
| Useful To Me Not Useful To Me | |||||
|
Sgvale
Supreme |
07-Jul-2020 15:19
|
||||
|
x 0
x 0 Alert Admin |
Medtec still going strong. Am starting to look at Biolidics again... | ||||
| Useful To Me Not Useful To Me | |||||
|
SQueeze
Master |
06-Jul-2020 16:26
|
||||
|
x 0
x 0 Alert Admin |
You are waiting for news of their new venture? They are re-strategizing the approach. It will take weeks or months..... it wouldn' t come in a week. better move on to other counters. If you still have this, leave it here and see again after 8 weeks or so.
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Sgvale
Supreme |
06-Jul-2020 13:46
|
||||
|
x 0
x 0 Alert Admin |
Exit 0.59. Claimed all losses in Biolidics & made much more !
|
||||
| Useful To Me Not Useful To Me | |||||
|
ST3-trading
Senior |
06-Jul-2020 11:46
|
||||
|
x 0
x 0 Alert Admin |
it has been 1 weeks . still no news on the development . | ||||
| Useful To Me Not Useful To Me | |||||
|
SQueeze
Master |
06-Jul-2020 10:33
|
||||
|
x 0
x 0 Alert Admin |
Don' t mix threads. Haha . I heart attack. i thought Biolidics zoomed from 0.415 to 0.575. Almost heart attack, because I am nurturing burn from buying at 0.415 and sold back at 0.29 so i can play more on medtecs to make up the stupid losses here.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Sgvale
Supreme |
06-Jul-2020 10:31
|
||||
|
x 0
x 0 Alert Admin |
Bought last wk 0.415. Now 0.575. Huat ah !@!
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Sgvale
Supreme |
06-Jul-2020 09:02
|
||||
|
x 0
x 0 Alert Admin |
Medtec 0.60 next. Turbo rise non stop | ||||
| Useful To Me Not Useful To Me | |||||
|
Vanpersie
Senior |
06-Jul-2020 08:14
|
||||
|
x 0
x 0 Alert Admin |
Is biolidcs involved in commercialising epidax ?
|
||||
| Useful To Me Not Useful To Me | |||||
|
Stockgod39
Member |
06-Jul-2020 07:09
|
||||
|
x 1
x 0 Alert Admin |
Biolidics may have made a tiny " mistake" in reporting - so what? Check out the news articles on NUS iHealthTech and the CNA video - both were released on 29 June 2020, the same date as the ST report. https://www.youtube.com/watch?v=1fg-ifm5wB8 https://ihealthtech.nus.edu.sg/news/epidax-a-fast-and-portable-point-of-care-covid-19-diagnostic-system/ https://news.nus.edu.sg/research/portable-point-care-test-covid-19-diagnosis https://ihealthtech.nus.edu.sg/news-events/?url=https://ihealthtech.nus.edu.sg/news/ihealthtech-joins-global-effort-to-fight-covid-19-virus/ They are clearly serious about this, and I choose to believe in them. |
||||
| Useful To Me Not Useful To Me | |||||
|
mw202020
Member |
05-Jul-2020 20:28
|
||||
|
x 0
x 0 Alert Admin |
Completely agree with this. Probably the concern now is whether this test kit venture is becoming a distraction to the company' s core business. Further, I think investors should seriously start considering whether this venture will eventually lead to a loss to the company (not just whether it will generate revenue and profits).
|
||||
| Useful To Me Not Useful To Me | |||||
|
Sgvale
Supreme |
05-Jul-2020 20:08
|
||||
|
x 0
x 0 Alert Admin |
Bio' s core business is the development of cell enrichment system. Just consider the venture of the test kits as their side line lo. If side line is able to generate revenue & profit will be added bonus. | ||||
| Useful To Me Not Useful To Me | |||||
|
Sgvale
Supreme |
05-Jul-2020 19:28
|
||||
|
x 0
x 0 Alert Admin |
Better refocus its cancer diagnostic & research.
Looks like its test kits venture can't take off as expected. |
||||
| Useful To Me Not Useful To Me | |||||
|
mw202020
Member |
05-Jul-2020 19:26
|
||||
|
x 0
x 0 Alert Admin |
" Company&rsquo s response: Under the terms of the Termination Agreement, Aytu will return the 13,000 COVID-19 Antibody Test Kits to the Company and the Company is not required to make a refund to Aytu for these returned test kits. The Company intends to distribute the COVID-19 Antibody Test Kits returned by Aytu to other markets outside of the US." Joke... Can' t even sell a single piece of the 13,000 kits supplied to Aytu. Wonder how many Bilidics actually sold in Asia. Also interesting to study Vazyme' website: http://www.vazymebiotech.com/COVID.html#dl. Contains agency information and an interesting " Cross Regional Sales Warning" statement. Looks like Vazyme has an exclusive agent for its kits in Indonesia, so it is possible that Biolidics can' t sell there. |
||||
| Useful To Me Not Useful To Me | |||||
|
mw202020
Member |
05-Jul-2020 18:52
|
||||
|
x 0
x 0 Alert Admin |
Biolidics test = Vazyme test If you see the FDA website (https://www.fda.gov/medical-devices/emergency-situations-medical-devices/faqs-testing-sars-cov-2), Vazyme test was actually rejected by the FDA. So if you put two and two together, a possible explanation for why Biolidics pulled out of the US market was because it saw that Vazyme was rejected, and by extension (because the 2 tests are really one and the same thing - only difference being the branding) its own test would be rejected too. So better to withdraw voluntarily than to get rejected. If that is so, then the Company is not being very forthcoming And not sure how Biolidics assertion that there is " ready demand" in Asia hold water. It would face the same keen competition in Asia too, wouldn' t it? This Company seems to only bring more questions than answers??? |
||||
| Useful To Me Not Useful To Me | |||||